Has Dipti Vyas received payments from drug or device companies?

Yes. Drug and device makers reported $1,573 in general payments to Dipti Vyas across 98 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dipti Vyas did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dipti Vyas come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dipti Vyas

Pediatrics · Greenwood, INNPI 1871508507

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $552 and has fallen 55.6% since, to $245 in 2025.

$1,573in general payments, 2019–2025

Across 98 payments — averaging $16.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$350
Pfizer$125
Otsuka America Pharmaceutical, Inc.$100
Bayer$87
Antares Pharma, Inc.$77
Axsome Therapeutics, Inc.$70
plus $764 from 26 others

What the payments were for

Food & beverage$1,573100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	22	$350
Pfizer	8	$125
Otsuka America Pharmaceutical, Inc.	5	$100
Bayer	5	$87
Antares Pharma, Inc.	5	$77
Axsome Therapeutics, Inc.	4	$70
Abbott	4	$61
GSK	4	$58
Amarin Pharma, Inc.	4	$55
Boehringer Ingelheim	4	$52
Biohaven Pharmaceutical Holding Company Ltd.	3	$51
Biogen	2	$40
Johnson & Johnson	2	$36
AbbVie	2	$35
IBSA Pharma Inc.	2	$35
Paratek Pharmaceuticals, Inc.	2	$32
Novo Nordisk	2	$32
Sanofi Pasteur Inc.	2	$32
Jazz Pharmaceuticals Inc.	2	$32
Kowa Pharmaceuticals America, Inc.	2	$23
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$21
Xeris Pharmaceuticals, Inc.	1	$18
Exact Sciences	1	$18
Phathom Pharmaceuticals, Inc.	1	$17
Nestle Healthcare Nutrition Inc.	1	$17
Merck	1	$16
Takeda Pharmaceuticals U.S.A., Inc.	1	$16
Dynavax Technologies Corporation	1	$16
Supernus Pharmaceuticals, Inc.	1	$15
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$14
Arbor Pharmaceuticals, Inc.	1	$11
Bausch Health US, LLC	1	$11

How this compares

$1,573 in reported general payments places this provider in the 85th percentile of 964 pediatrics providers in Indiana.

See all pediatrics providers in Indiana →

Other pediatrics in Greenwood

James ShmaloGreenwood$2K
Chris HolmesLinton$222K
Jori MatushekWestfield$121K
Fredrick MayIndianapolis$102K
Alexis YooFishers$47K
Christa GoebesIndianapolis$18K
Brian AguilarMcCordsville$12K
Nerissa BauerCarmel$10K
Jeb TeichmanJeffersonville$9K
Paul WolfeMarion$7K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →